Annual CAPEX
$21.16 M
+$984.00 K+4.88%
31 December 2023
Summary:
Sangamo Therapeutics annual capital expenditures is currently $21.16 million, with the most recent change of +$984.00 thousand (+4.88%) on 31 December 2023. During the last 3 years, it has risen by +$6.44 million (+43.77%). SGMO annual CAPEX is now -50.88% below its all-time high of $43.06 million, reached on 31 December 2018.SGMO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$115.00 K
0.00%
30 September 2024
Summary:
Sangamo Therapeutics quarterly capital expenditures is currently $115.00 thousandOver the past year, it has dropped by -$2.63 million (-95.81%). SGMO quarterly CAPEX is now -99.59% below its all-time high of $28.04 million, reached on 31 December 2018.SGMO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$2.79 M
0.00%
30 September 2024
Summary:
Sangamo Therapeutics TTM capital expenditures is currently $2.79 millionOver the past year, it has dropped by -$23.17 million (-89.27%). SGMO TTM CAPEX is now -94.08% below its all-time high of $47.06 million, reached on 30 June 2019.SGMO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.9% | -95.8% | -89.3% |
| 3 y3 years | +43.8% | -97.8% | -88.6% |
| 5 y5 years | -50.9% | -97.2% | -93.4% |
SGMO CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -9.1% | +43.8% | -98.9% | at low | -89.9% | at low |
| 5 y | 5 years | -50.9% | +43.8% | -98.9% | at low | -93.4% | at low |
| alltime | all time | -50.9% | >+9999.0% | -99.6% | +104.9% | -94.1% | +253.3% |
Sangamo Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $115.00 K(-95.7%) | $2.79 M(-86.8%) |
| Dec 2023 | $21.16 M(+4.9%) | $2.67 M(-2.7%) | $21.16 M(-18.5%) |
| Sept 2023 | - | $2.74 M(-50.5%) | $25.96 M(-6.0%) |
| June 2023 | - | $5.54 M(-45.7%) | $27.63 M(+0.3%) |
| Mar 2023 | - | $10.20 M(+36.5%) | $27.53 M(+36.5%) |
| Dec 2022 | $20.17 M(-13.3%) | $7.47 M(+69.4%) | $20.17 M(+29.7%) |
| Sept 2022 | - | $4.41 M(-19.0%) | $15.55 M(-4.9%) |
| June 2022 | - | $5.45 M(+91.8%) | $16.35 M(-10.0%) |
| Mar 2022 | - | $2.84 M(-0.7%) | $18.17 M(-22.0%) |
| Dec 2021 | $23.28 M(+58.2%) | $2.86 M(-45.1%) | $23.28 M(-4.7%) |
| Sept 2021 | - | $5.21 M(-28.3%) | $24.43 M(+5.2%) |
| June 2021 | - | $7.26 M(-8.6%) | $23.23 M(+23.0%) |
| Mar 2021 | - | $7.95 M(+98.2%) | $18.89 M(+28.4%) |
| Dec 2020 | $14.71 M(-28.8%) | $4.01 M(+0.0%) | $14.71 M(-15.8%) |
| Sept 2020 | - | $4.01 M(+37.3%) | $17.48 M(-0.7%) |
| June 2020 | - | $2.92 M(-22.7%) | $17.61 M(-4.7%) |
| Mar 2020 | - | $3.77 M(-44.3%) | $18.47 M(-10.7%) |
| Dec 2019 | $20.68 M(-52.0%) | $6.78 M(+64.0%) | $20.68 M(-50.7%) |
| Sept 2019 | - | $4.13 M(+9.3%) | $41.93 M(-10.9%) |
| June 2019 | - | $3.78 M(-36.7%) | $47.06 M(+1.4%) |
| Mar 2019 | - | $5.98 M(-78.7%) | $46.43 M(+7.8%) |
| Dec 2018 | $43.06 M(+1048.1%) | $28.04 M(+202.8%) | $43.06 M(+170.7%) |
| Sept 2018 | - | $9.26 M(+193.8%) | $15.91 M(+116.6%) |
| June 2018 | - | $3.15 M(+20.5%) | $7.34 M(+24.5%) |
| Mar 2018 | - | $2.62 M(+197.9%) | $5.90 M(+57.3%) |
| Dec 2017 | $3.75 M(+412.4%) | $878.00 K(+25.8%) | $3.75 M(+21.2%) |
| Sept 2017 | - | $698.00 K(-59.1%) | $3.10 M(+21.4%) |
| June 2017 | - | $1.71 M(+264.7%) | $2.55 M(+169.1%) |
| Mar 2017 | - | $468.00 K(+109.9%) | $948.00 K(+29.5%) |
| Dec 2016 | $732.00 K(+69.4%) | $223.00 K(+45.8%) | $732.00 K(-140.3%) |
| Sept 2016 | - | $153.00 K(+47.1%) | -$1.82 M(+5.3%) |
| June 2016 | - | $104.00 K(-58.7%) | -$1.73 M(+107.5%) |
| Mar 2016 | - | $252.00 K(-110.8%) | -$832.00 K(<-9900.0%) |
| Dec 2015 | - | -$2.33 M(-1049.8%) | $0.00(-100.0%) |
| Sept 2015 | - | $245.00 K(-75.5%) | $1.77 M(+9.3%) |
| June 2015 | - | $998.00 K(-7.9%) | $1.62 M(+68.8%) |
| Mar 2015 | - | $1.08 M(-293.9%) | $958.00 K(>+9900.0%) |
| Dec 2014 | - | -$559.00 K(-694.7%) | $0.00(-100.0%) |
| Sept 2014 | - | $94.00 K(-72.3%) | $596.00 K(+8.8%) |
| June 2014 | - | $339.00 K(+169.0%) | $548.00 K(+11.8%) |
| Mar 2014 | - | $126.00 K(+240.5%) | $490.00 K(+13.4%) |
| Dec 2013 | $432.00 K(-40.2%) | $37.00 K(-19.6%) | $432.00 K(-42.8%) |
| Sept 2013 | - | $46.00 K(-83.6%) | $755.00 K(-6.7%) |
| June 2013 | - | $281.00 K(+313.2%) | $809.00 K(+41.2%) |
| Mar 2013 | - | $68.00 K(-81.1%) | $573.00 K(-20.7%) |
| Dec 2012 | $723.00 K | $360.00 K(+260.0%) | $723.00 K(+27.3%) |
| Sept 2012 | - | $100.00 K(+122.2%) | $568.00 K(-11.7%) |
| June 2012 | - | $45.00 K(-79.4%) | $643.00 K(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $218.00 K(+6.3%) | $684.00 K(+18.8%) |
| Dec 2011 | $576.00 K(-17.1%) | $205.00 K(+17.1%) | $576.00 K(+33.3%) |
| Sept 2011 | - | $175.00 K(+103.5%) | $432.00 K(+21.3%) |
| June 2011 | - | $86.00 K(-21.8%) | $356.00 K(-15.4%) |
| Mar 2011 | - | $110.00 K(+80.3%) | $421.00 K(-39.4%) |
| Dec 2010 | $695.00 K(+155.5%) | $61.00 K(-38.4%) | $695.00 K(-9.4%) |
| Sept 2010 | - | $99.00 K(-34.4%) | $767.00 K(+7.9%) |
| June 2010 | - | $151.00 K(-60.7%) | $711.00 K(+18.3%) |
| Mar 2010 | - | $384.00 K(+188.7%) | $601.00 K(+121.0%) |
| Dec 2009 | $272.00 K(-63.2%) | $133.00 K(+209.3%) | $272.00 K(+66.9%) |
| Sept 2009 | - | $43.00 K(+4.9%) | $163.00 K(-45.8%) |
| June 2009 | - | $41.00 K(-25.5%) | $301.00 K(-29.8%) |
| Mar 2009 | - | $55.00 K(+129.2%) | $429.00 K(-41.9%) |
| Dec 2008 | $739.00 K(-46.0%) | $24.00 K(-86.7%) | $739.00 K(-41.7%) |
| Sept 2008 | - | $181.00 K(+7.1%) | $1.27 M(-5.0%) |
| June 2008 | - | $169.00 K(-53.7%) | $1.33 M(-17.0%) |
| Mar 2008 | - | $365.00 K(-34.0%) | $1.61 M(+17.5%) |
| Dec 2007 | $1.37 M(+266.0%) | $553.00 K(+123.0%) | $1.37 M(+30.0%) |
| Sept 2007 | - | $248.00 K(-43.9%) | $1.05 M(+30.8%) |
| June 2007 | - | $442.00 K(+250.8%) | $805.00 K(+181.5%) |
| Mar 2007 | - | $126.00 K(-46.8%) | $286.00 K(-23.5%) |
| Dec 2006 | $374.00 K(-12.6%) | $237.00 K(>+9900.0%) | $374.00 K(+4.5%) |
| Sept 2006 | - | $0.00(-100.0%) | $358.00 K(-6.8%) |
| June 2006 | - | -$77.00 K(-136.0%) | $384.00 K(-37.5%) |
| Mar 2006 | - | $214.00 K(-3.2%) | $614.00 K(+43.5%) |
| Dec 2005 | $428.00 K(+1683.3%) | $221.00 K(+750.0%) | $428.00 K(+97.2%) |
| Sept 2005 | - | $26.00 K(-83.0%) | $217.00 K(+11.3%) |
| June 2005 | - | $153.00 K(+446.4%) | $195.00 K(+364.3%) |
| Mar 2005 | - | $28.00 K(+180.0%) | $42.00 K(+75.0%) |
| Dec 2004 | $24.00 K(-62.5%) | $10.00 K(+150.0%) | $24.00 K(-20.0%) |
| Sept 2004 | - | $4000.00(>+9900.0%) | $30.00 K(+15.4%) |
| June 2004 | - | $0.00(-100.0%) | $26.00 K(-45.8%) |
| Mar 2004 | - | $10.00 K(-37.5%) | $48.00 K(-25.0%) |
| Dec 2003 | $64.00 K(-7.2%) | $16.00 K(>+9900.0%) | $64.00 K(-29.7%) |
| Sept 2003 | - | $0.00(-100.0%) | $91.00 K(-2.2%) |
| June 2003 | - | $22.00 K(-15.4%) | $93.00 K(-2.1%) |
| Mar 2003 | - | $26.00 K(-39.5%) | $95.00 K(+37.7%) |
| Dec 2002 | $69.00 K(-95.1%) | $43.00 K(+2050.0%) | $69.00 K(-145.4%) |
| Sept 2002 | - | $2000.00(-91.7%) | -$152.00 K(-145.5%) |
| June 2002 | - | $24.00 K(-113.5%) | $334.00 K(-76.2%) |
| Dec 2001 | $1.40 M(-19.8%) | -$178.00 K(-136.5%) | $1.40 M(-35.7%) |
| Sept 2001 | - | $488.00 K(-21.5%) | $2.18 M(+13.0%) |
| June 2001 | - | $622.00 K(+32.1%) | $1.93 M(-5.8%) |
| Mar 2001 | - | $471.00 K(-21.6%) | $2.05 M(+17.1%) |
| Dec 2000 | $1.75 M(+483.3%) | $601.00 K(+153.6%) | $1.75 M(+52.3%) |
| Sept 2000 | - | $237.00 K(-68.0%) | $1.15 M(+26.0%) |
| June 2000 | - | $740.00 K(+330.2%) | $912.00 K(+430.2%) |
| Mar 2000 | - | $172.00 K | $172.00 K |
| Dec 1999 | $300.00 K | - | - |
FAQ
- What is Sangamo Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual CAPEX year-on-year change?
- What is Sangamo Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly CAPEX year-on-year change?
- What is Sangamo Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Sangamo Therapeutics?
- What is Sangamo Therapeutics TTM CAPEX year-on-year change?
What is Sangamo Therapeutics annual capital expenditures?
The current annual CAPEX of SGMO is $21.16 M
What is the all time high annual CAPEX for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual capital expenditures is $43.06 M
What is Sangamo Therapeutics annual CAPEX year-on-year change?
Over the past year, SGMO annual capital expenditures has changed by +$984.00 K (+4.88%)
What is Sangamo Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of SGMO is $115.00 K
What is the all time high quarterly CAPEX for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly capital expenditures is $28.04 M
What is Sangamo Therapeutics quarterly CAPEX year-on-year change?
Over the past year, SGMO quarterly capital expenditures has changed by -$2.63 M (-95.81%)
What is Sangamo Therapeutics TTM capital expenditures?
The current TTM CAPEX of SGMO is $2.79 M
What is the all time high TTM CAPEX for Sangamo Therapeutics?
Sangamo Therapeutics all-time high TTM capital expenditures is $47.06 M
What is Sangamo Therapeutics TTM CAPEX year-on-year change?
Over the past year, SGMO TTM capital expenditures has changed by -$23.17 M (-89.27%)